Product Information
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET is a generic product labeled by Mikart, LLC, priced at $0.1218 per EA under NDC 46672005350. Its NADAC has been published 657 times since Nov 28, 2013.
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET
butalbital, acetaminophen and caffeineStrength
325; 50; 40 mg/1; mg/1; mg/1
Manufacturer
Mikart, LLCNDC
46672005350
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ACETAMINOPHEN; BUTALBITAL; CAFFEINEApproval Type
Generic (ANDA)
FDA Application
ANDA089175On Market Since
1/21/1987
Pharmacological Classes
Price Statistics
The NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 47.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1218 per EA |
|---|---|
| All-time high | $0.8719 (May 11, 2016) |
| All-time low | $0.0825 (Nov 28, 2013) |
| 52-week high | $0.1493 |
| 52-week low | $0.1218 |
| Median price | $0.1985 |
| Average price | $0.3145 |
| Largest weekly change | +538.4% (Jun 18, 2014) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET, manufactured by Mikart, LLC, is $0.1218 per EA (NDC 46672005350), effective Jun 24, 2026.
How has the price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET has risen 47.6%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET?
Since Nov 28, 2013, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET has ranged from a low of $0.0825 (Nov 28, 2013) to a high of $0.8719 (May 11, 2016), with a median of $0.1985 per EA.
Are there cheaper alternatives to BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET, but none are currently priced below it.
Who manufactures BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET?
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET (NDC 46672005350) is labeled by Mikart, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification